Gabapentin 100 mg Capsules Recalled by Major Pharmaceuticals in 2025, 100-Count Pack
Major Pharmaceuticals recalled Gabapentin capsules, 100 mg, 100-count, distributed nationwide in the United States. The recall stems from an out-of-spec highest unknown impurity found during stability testing. Healthcare providers and patients should stop using the product and contact The Harvard Drug Group LLC for guidance.